Healwell AI Inc. (TSX:AIDX)
Canada · Delayed Price · Currency is CAD 0.7900
+0.0200 (2.60%)
Aug 21, 2026, 3:58 PM EST
Healwell AI Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 128.74 | 103.8 | 19.71 | 7.32 | 10.42 | 47.82 | |
Revenue Growth | 135.29% | 426.63% | 169.39% | -29.81% | -78.20% | 23.96% |
Cost of Revenue | 57.18 | 46.51 | 8.89 | 6.06 | 6.71 | 32.81 |
Gross Profit | 71.56 | 57.29 | 10.82 | 1.26 | 3.71 | 15.01 |
Selling, General & Admin | 44.09 | 37.87 | 22.26 | 13.26 | 13.78 | 33 |
Research & Development | 19.88 | 16.42 | 5.8 | 4.81 | 8.14 | 0.16 |
Amortization of Goodwill & Intangibles | 15.48 | 14.31 | 5.73 | - | - | - |
Operating Expenses | 92.93 | 84.18 | 41.27 | 18.08 | 21.92 | 33.15 |
Operating Income | -21.37 | -26.89 | -30.45 | -16.82 | -18.21 | -18.14 |
Interest Expense | -13.34 | -10.16 | -2.37 | -2 | -0.62 | -0.46 |
Interest & Investment Income | 0.57 | 0.57 | 0.54 | 0.24 | 0.02 | 0.11 |
Earnings From Equity Investments | - | - | - | - | -0.21 | - |
Currency Exchange Gain (Loss) | -3.38 | -2.15 | - | - | - | - |
Other Non Operating Income (Expenses) | 3.63 | 4.52 | -0.95 | - | -0.04 | -0.1 |
EBT Excluding Unusual Items | -33.89 | -34.12 | -33.23 | -18.57 | -19.06 | -18.6 |
Merger & Restructuring Charges | -2.63 | -2.63 | - | - | - | - |
Impairment of Goodwill | - | - | -4.51 | -5.18 | - | - |
Gain (Loss) on Sale of Investments | 18.37 | 1.2 | 0.28 | -2.31 | -0.4 | - |
Gain (Loss) on Sale of Assets | -1.42 | -1.42 | - | - | - | - |
Asset Writedown | - | - | -1.1 | -5.72 | - | - |
Other Unusual Items | -2.06 | -2.81 | 13.53 | -0.9 | 1.64 | 1.64 |
Pretax Income | -21.64 | -39.78 | -25.03 | -32.68 | -17.08 | -16.29 |
Income Tax Expense | 1.57 | -0.66 | -1.07 | -0.54 | 1.12 | -0.75 |
Earnings From Continuing Operations | -23.21 | -39.12 | -23.96 | -32.14 | -18.2 | -15.54 |
Earnings From Discontinued Operations | -6.73 | -8.54 | -3.52 | 0.6 | -2.78 | - |
Net Income to Company | -29.94 | -47.66 | -27.48 | -31.55 | -20.97 | -15.54 |
Minority Interest in Earnings | 0.32 | 0.55 | 1.19 | -0.05 | -0.12 | -0.13 |
Net Income | -29.62 | -47.11 | -26.29 | -31.6 | -21.09 | -15.67 |
Net Income to Common | -29.62 | -47.11 | -26.29 | -31.6 | -21.09 | -15.67 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 289 | 251 | 136 | 57 | 50 | 48 |
Shares Outstanding (Diluted) | 289 | 251 | 136 | 57 | 50 | 48 |
Shares Change | 52.55% | 84.82% | 137.69% | 13.89% | 4.33% | 25.22% |
EPS (Basic) | -0.10 | -0.19 | -0.19 | -0.55 | -0.42 | -0.33 |
EPS (Diluted) | -0.10 | -0.19 | -0.19 | -0.55 | -0.42 | -0.33 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.09 | -20.16 | -22.71 | -10.86 | -8.64 | -7.93 |
Free Cash Flow Per Share | -0.02 | -0.08 | -0.17 | -0.19 | -0.17 | -0.17 |
Gross Margin | 55.59% | 55.19% | 54.90% | 17.18% | 35.59% | 31.39% |
Operating Margin | -16.60% | -25.91% | -154.47% | -229.85% | -174.68% | -37.94% |
Profit Margin | -23.01% | -45.38% | -133.39% | -431.83% | -202.27% | -32.77% |
Free Cash Flow Margin | -4.73% | -19.42% | -115.22% | -148.48% | -82.87% | -16.59% |
EBITDA | -19.04 | -20.59 | -28.32 | -15.34 | -16.73 | -17.05 |
EBITDA Margin | -14.79% | -19.84% | -143.68% | -209.64% | -160.45% | -35.66% |
D&A For EBITDA | 2.34 | 6.3 | 2.13 | 1.48 | 1.48 | 1.09 |
EBIT | -21.37 | -26.89 | -30.45 | -16.82 | -18.21 | -18.14 |
EBIT Margin | -16.60% | -25.91% | -154.47% | -229.85% | -174.68% | -37.94% |
Revenue as Reported | 128.74 | 103.8 | 19.71 | - | - | - |